Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Diversity, Equity, and Inclusion (DEI)
Hematology Disease Topics & Pathways:
Diversity, Equity, and Inclusion (DEI)
Saturday, December 7, 2024: 6:00 PM-9:00 PM
Marina Ballroom D
(Marriott Marquis San Diego Marina)
Moderators:
Anita D'Souza, MD, Medical College of Wisconsin
and
Jorge Monge, MD, University of Colorado Anschutz Medical Campus
and
Mazie Tsang, MD, Mayo Clinic
Disclosures:
Monge: Janssen: Consultancy; Johnson & Johnson: Consultancy; Pfizer: Consultancy. Tsang: AstraZeneca: Other: Advisory Board; Poseida Therapeutics: Current holder of stock options in a privately-held company; AVEO: Other: Prior holder of stock options in a privately-held company; Novartis: Other: Advisory Board; Genentech: Other: Advisory Board.
The Hematology Inclusion Pathway Presentations and Reception (previously known as Promoting Minorities in Hematology); ASH invites all interested meeting attendees to this event, which will showcase the research of our Hematology Inclusion Pathway awardees. This initiative is a comprehensive 13-year longitudinal career pathway of awards that strives to ensure that hematology reflects and serves the diverse world we live in. The highlight of the session will be oral scientific presentations from program participants.
See more of: Special-Interest Sessions